Medical device pioneer Stentys announced today that the complete 'OPEN-I' clinical study was presented by Stefan Verheye, M.D., Ph.D., at the Joint Interventional Meeting ("JIM") 2010 in Rome, demonstrating superior results in 60 patients (27 Stentys drug-eluting stents and 33 Stentys bare-metal stents) who were followed - up angiographically after six months. "These clinical results suggest very promising benefits for patients," said Stefan Verheye, M.D., Ph.D., Department of Cardiology, Middelheim Hospital, Antwerp, Belgium... 
More...
More...